We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.50 | 0.62% | 1,715.50 | 1,715.00 | 1,715.50 | 1,720.50 | 1,695.50 | 1,705.00 | 1,741,471 | 14:48:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.33 | 70.63B |
Date | Subject | Author | Discuss |
---|---|---|---|
17/11/2017 18:11 | so the focus is that simple...the thing is, the market don’t care yet, they are concerned about dividend growth and debt... and maybe the new ceo lol so we all have to wait and see the new products start bringing in the money....arent you the one who said the share price wouldn't go lower? crystal ball stuff lol | mj19 | |
17/11/2017 18:00 | Stop talking dividends.... this company just launched 2 blockbusters! | tradermichael | |
17/11/2017 17:10 | Growing UK political risks hanging heavy over utilities. | essentialinvestor | |
17/11/2017 17:09 | Annoying really as it always can get cheaper... | mj19 | |
17/11/2017 17:01 | Mj forgive me for one post on Ng on this thread but surely that fall is way overdone. a uk interest rates are unlikely to rise dramatically in the near term B the dividend is solid C political risk seems to be discounted | atlantic57 | |
17/11/2017 16:44 | It's pay up time for years of overly generous dividends, the price for those is now reflected in the share price. | essentialinvestor | |
17/11/2017 16:40 | i know that feeling, bought national grid it tanked, bought centrica it tanked... so nothing is safe... at the moment I only hold GSK and Barc and neither is doing anything special | mj19 | |
17/11/2017 16:33 | Mj that is very helpful thanks . I am struggling to think of Uk Companies that I would invest in just at the moment | atlantic57 | |
17/11/2017 16:23 | The problem is the debt hence no bidder GlaxoSmithKline currently boasts $5.3 billion in cash in the bank -- but it also carries $24.4 billion in debt. Had Glaxo held onto its cash, it would be rich A consequence of Glaxo's weak profits is that the company's payout ratio (the percentage of Glaxo's profits that are paid out to shareholders in the form of dividends) now exceeds 200%. Put another way, for every $1 Glaxo earns in profits, the company pays its shareholders $2 in dividends -- $1 that it has, and $1 that it has to borrow. This is not a sustainable dividend policy, hence the drama but they are paying it through 2018... after that who knows.. | mj19 | |
17/11/2017 16:09 | Surely at this valuation the company would be a very tempting bid target or am I being to simplistic | atlantic57 | |
17/11/2017 15:39 | Onward and downward. Next possible support 12718 unless it want to go the 'whole hog' at 12279. GSK DAILY | bracke | |
17/11/2017 15:12 | 12.50 anyone? | bennodean | |
17/11/2017 14:53 | Even I am getting tempted now . | redips2 | |
17/11/2017 14:48 | Here we go, will it hold.. | essentialinvestor | |
17/11/2017 10:15 | Technically very oversold | juju44 | |
17/11/2017 09:57 | We avoided a test of £13 yesterday because of US market strength imv. | essentialinvestor | |
17/11/2017 09:01 | just bought some here . Fall looks overdone | juju44 | |
17/11/2017 08:59 | MJ19...bit premature? | bili1946 | |
16/11/2017 20:27 | At last we rise yeahhhhh | mj19 | |
16/11/2017 13:42 | Trelegy/closed triple, looks a great product, it's a case of whether insurers/health services will pay the price difference to simplify a medication regime. From memory trials appear to show some incremental benefit in reducing exacerbations. | essentialinvestor | |
16/11/2017 13:36 | It's giving the impression of being dragged towards £13 like some whirlpool effect, hopefully not. | essentialinvestor | |
16/11/2017 13:21 | Nope, there's clearly an agenda here. Still, can buy nice'n'cheap while it lasts. | woodhawk | |
16/11/2017 13:17 | is there no piece of good news that can make this rise. | spoole5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions